P1.01-42 Real-World Evaluation of Tolerability in Older Adult Patients (≥75 Years Old) With EGFR-mutated NSCLC
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.598
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV